| Indicators | Browse All

Palatin Technologies, Inc. (PTN)

Healthcare | Biotechnology | Monmouth Junction, United States | NasdaqCM
10.48 USD +0.22 (2.144%) ⇧ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 11.00 +0.52 (4.962%) ⇧ (Aug. 28, 2026, 6:38 p.m. EDT)

Short-term:★★☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 4:57 a.m. EDT

The immediate outlook remains deeply bearish as the stock continues to grind lower against its moving averages, with the recent price action showing a distinct lack of recovery despite a brief spike earlier in the session. The statistical forecast model, while offering low confidence, leans negative, reinforcing the technical weakness. However, the primary driver for avoiding this name is the catastrophic long-term trajectory: the business has suffered seven consecutive years of negative annual returns, culminating in a nearly 99% collapse in value over the last nine years. This is not a temporary correction but a structural implosion where the market has repeatedly rejected the company's performance. Fundamentally, the picture is dire; the company is burning through cash with negative free cash flow, negative operating margins, and negative returns on both assets and equity. While the balance sheet currently shows low debt relative to equity, the relentless bleed in profitability and the complete absence of any dividend history suggest a company struggling to sustain operations rather than a value opportunity waiting to be discovered. With no revenue growth to speak of and a forward P/E that implies massive future losses, there is no logical case for a multi-year hold.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.227471
MSTL0.355598
AutoARIMA0.359829
AutoETS0.361664

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 35%
H-stat 5.01
Ljung-Box p 0.000
Jarque-Bera p 0.206
Excess Kurtosis -1.21
Attribute Value
Sector Healthcare
Debt to Equity Ratio 2.706
Revenue per Share 6.277
Market Cap 18,646,802
Trailing P/E 95.27
Forward P/E -4.31
Beta -0.10
Profit Margins -48.50%
Website https://palatin.com

Info Dump

Attribute Value
52 Week Change 0.104210496
Address1 11 Deer Park Drive
Address2 Suite 204
All Time High 128,125.0
All Time Low 2.0
Ask 10.83
Ask Size 1
Average Daily Volume10 Day 29,660
Average Daily Volume3 Month 21,156
Average Volume 21,156
Average Volume10Days 29,660
Beta -0.098
Bid 10.07
Bid Size 1
Book Value 5.963
City Monmouth Junction
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 10.48
Current Ratio 5.041
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 11.11
Day Low 9.65
Debt To Equity 2.706
Display Name Palatin
Ebitda -8,752,423
Ebitda Margins -0.67931
Enterprise To Ebitda -1.002
Enterprise To Revenue 0.681
Enterprise Value 8,774,044
Eps Current Year -2.99
Eps Forward -2.43
Eps Trailing Twelve Months 0.11
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 9.508
Fifty Day Average Change 0.97199917
Fifty Day Average Change Percent 0.10222961
Fifty Two Week Change Percent 10.421049
Fifty Two Week High 31.0
Fifty Two Week High Change -20.52
Fifty Two Week High Change Percent -0.6619355
Fifty Two Week Low 5.61
Fifty Two Week Low Change 4.8699994
Fifty Two Week Low Change Percent 0.86809254
Fifty Two Week Range 5.61 - 31.0
Financial Currency USD
First Trade Date Milliseconds 876,922,200,000
Float Shares 1,487,385
Forward Eps -2.43
Forward P E -4.312757
Free Cashflow -13,673,166
Full Exchange Name NasdaqCM
Full Time Employees 29
Fullday Change 0.219999
Fullday Change Percent 2.14424
Fullday Price 11.0
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0428
Gross Profits 551,402
Has Pre Post Market Data 1
Held Percent Insiders 0.07861
Held Percent Institutions 0.50156
Implied Shares Outstanding 1,779,275
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,026-05-29
Language en-US
Last Fiscal Year End 1,751,241,600
Last Split Date 1,754,956,800
Last Split Factor 1:50
Long Business Summary Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Long Name Palatin Technologies, Inc.
Market us_market
Market Cap 18,646,802
Market State CLOSED
Max Age 86,400
Message Board Id finmb_32651
Most Recent Quarter 1,774,915,200
Net Income To Common -6,249,112
Next Fiscal Year End 1,782,777,600
Non Diluted Market Cap 18,664,594
Number Of Analyst Opinions 3
Open 10.5596
Operating Cashflow -14,932,332
Operating Margins -0.40325
Payout Ratio 0.0
Peg Ratio 1.62
Phone 609 495 2200
Post Market Change 0.52000046
Post Market Change Percent 4.961837
Post Market Price 11.0
Post Market Time 1,787,956,721
Previous Close 10.26
Price Eps Current Year -3.5050166
Price Hint 2
Price To Book 1.7575046
Price To Sales Trailing12 Months 1.4472543
Profit Margins -0.48501998
Quick Ratio 4.861
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.21999931
Regular Market Change Percent 2.1442428
Regular Market Day High 11.11
Regular Market Day Low 9.65
Regular Market Day Range 9.65 - 11.11
Regular Market Open 10.5596
Regular Market Previous Close 10.26
Regular Market Price 10.48
Regular Market Time 1,787,947,200
Regular Market Volume 128,989
Return On Assets -0.65259004
Return On Equity -2.9723902
Revenue Per Share 6.277
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 1,779,275
Shares Percent Shares Out 0.19639999
Shares Short 349,501
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 303,782
Short Name Palatin Technologies, Inc.
Short Percent Of Float 0.2065
Short Ratio 17.71
Source Interval 15
State NJ
Symbol PTN
Target High Price 60.0
Target Low Price 47.5
Target Mean Price 53.5
Target Median Price 53.0
Total Cash 10,159,494
Total Cash Per Share 5.71
Total Debt 286,662
Total Revenue 12,884,261
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.11
Trailing P E 95.27272
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 16.0176
Two Hundred Day Average Change -5.5375996
Two Hundred Day Average Change Percent -0.3457197
Type Disp Equity
Volume 128,989
Website https://palatin.com
Zip 8,512